genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
Takeda Pharmaceutical Company
Bioprocessing
Reducing Risk and Illustrating Benefits Speed Innovation
Coronavirus
ACTIV Partner: NIH Aims to Accelerate COVID-19 Drug, Vaccine Development
News
Novavax – NVX-CoV2373 (Nuvaxovid™ in Europe and Australia; COVOVAX™ in India and the Philippines; TAK-019 in Japan)
News
Takeda Pharmaceutical
Coronavirus
Coronavirus: Takeda Pursues Plasma-Derived Treatment; Alnylam and Vir Eye siRNA Therapy
Drug Discovery
Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial
A-Lists
10 Takeover Targets to Watch This Fall
Cancer
Takeda Sells Two Drugs for $5.7B+, Licenses a Third, in Deals Aimed at Refocusing Pipeline
Genome Editing
Takeda Inks Licensing Option Agreement with Gene Editing Platform Developer Emendo
Featured
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
1
2
3
4
...
20
Page 3 of 20
Scroll Up
Scroll Up
